Answers are grounded in this paper and cite their sources.
OBJECTIVES: Serum phosphate levels commonly decline during treatment of pediatric diabetic ketoacidosis (DKA), but the determinants and clinical implications of hypophosphatemia remain incompletely defined. We aimed to determine its incidence, predictors, and clinical impact during pediatric DKA. METHODS: In this retrospective study, 116 DKA episodes managed in a tertiary pediatric emergency department and intensive care unit between January 2022 and June 2025 were analyzed. Demographic characteristics, admission biochemical parameters, and clinical outcomes were recorded. Hypophosphatemia was defined according to age-specific reference ranges. Multivariable logistic regression identified independent predictors of hypophosphatemia, while length of hospital stay was assessed using multivariable linear regression of log-transformed values. RESULTS: Hypophosphatemia occurred in 72/116 episodes (62.1%). Compared with those without hypophosphatemia, affected patients had lower admission pH (7.03±0.13 vs. 7.12±0.17; P=0.002), bicarbonate (7.8±2.4 vs. 9.8±3.3 mEq/L; P<0.001), and potassium levels (4.43±0.96 vs. 4.81±0.66 mEq/L; P=0.024). Hyponatremia and hypokalemia were more frequent, whereas hyperkalemia was less common (all P<0.05). Lower admission pH (OR: 0.008, 95% CI: 0.000-0.219; P=0.004) and lower baseline phosphate concentration (OR: 0.67, 95% CI: 0.47-0.97; P=0.031) independently predicted hypophosphatemia. Although hospitalization was longer in the hypophosphatemia group (85.3±75.2 vs. 56.2±36.4 h; P=0.018), hypophosphatemia was not independently associated with length of stay. Higher admission pH independently predicted shorter hospitalization (β=-0.957, P=0.026). Baseline phosphate positively correlated with nadir phosphate during treatment (r=0.303, P<0.001). CONCLUSIONS: Hypophosphatemia is common during pediatric DKA and is closely associated with the severity of metabolic acidosis at presentation. However, it does not independently affect hospitalization duration, suggesting that it primarily reflects disease severity rather than independently determining short-term outcomes.
No takes yet. Share an insight, caveat, or question.
Tosun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: